<DOC>
	<DOCNO>NCT01850212</DOCNO>
	<brief_summary>A Phase 4 study characterize profile low bone mineral density ( BMD ) ≥ 50 year old male subject post-menopausal female subject tenofovir disoproxil fumarate ( TDF ) -based regimen</brief_summary>
	<brief_title>A Phase 4 Cross-Sectional Study Bone Mineral Density HIV-1 Infected Subjects</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<criteria>Must ability understand sign write informed consent form , must obtain prior initiation study procedure . HIV1 infected subject regardless race ethnicity Use one follow take stable , continuous , NRTIcontaining antiretroviral ( ARV ) regimen ≥ 3 year allow ( withinclass change agent TDF within 3 year study entry permit specify ) : TDF plus PI/rcontaining regimen include subject switch one TDF plus PI/r regimen another TDF plus PI/r regimen TDF plus nonPI/rcontaining regimen include subject switch one TDF plus nonPI/r regimen another TDF plus nonPI/r regimen NonTDF NRTI plus PI/rcontaining regimen include subject switch one nonTDF NRTI plus PI/r regimen another nonTDF NRTI regimen plus PI/r regimen NonTDF NRTI plus nonPI/r‑containing regimen include subject switch one nonTDF NRTI plus nonPI/r regimen another nonTDF NRTI regimen plus non‑PI/r regimen Of note , subject nonTDF group must never take regimen include TDF ( include previous exposure TDF preexposure prophylaxis ( PrEP ) ) Subjects include TDF group must always take regimen include TDF . NonPI/r agent include nonnucleoside reverse transcriptase inhibitor ( NNRTIs ) , integrase inhibitor , triple nucleoside inhibitor nonboosted protease inhibitor Male subject must ≥ 50 year age Female subject must postmenopausal . Menopause assume occur woman either appropriate medical documentation prior complete bilateral oophorectomy permanent cessation previously occur menses &gt; 12 month result ovarian failure bilateral oophorectomy documentation hormonal deficiency certify healthcare provide Adequate record available evaluate medical history 3 year prior study entry Subject contraindication dualenergy Xray absorptiometry ( DEXA ) scan Subject history osteoporosis initiate Highly Active Antiretroviral Treatment ( HAART )</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Treatment Experienced</keyword>
	<keyword>Male great equal 50 year</keyword>
	<keyword>Female postmenopausal</keyword>
</DOC>